Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

计划入组 133 人 · 首次发布于 2022 年 10 月 7 日

Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection

计划入组 246 人 · 首次发布于 2021 年 2 月 16 日

Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England

计划入组 18,373,714 人 · 首次发布于 2021 年 9 月 17 日

AZD-9838

AstraZeneca COVID-19 Vaccine(Vaxzevria)

MEDI 9287

AstraZeneca

United Kingdom

ASTRAZENECA K.K.

Japan

AstraZeneca AG

Switzerland

EMA Advises Against AstraZeneca Vaccine for Individuals with Capillary Bleeding Syndrome

EMA Official Confirms Link Between AstraZeneca Vaccine and Rare Blood Clots

EU Anticipated to Approve Oxford-AstraZeneca COVID-19 Vaccine This Week